Myriad Genetics (MYGN) Cash from Operations Growth (5y) (2014 - 2026)
Myriad Genetics (MYGN) Cash from Operations Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Myriad Genetics | 296.09 Mn | 171.69 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.28% |
| Dec 31, 2025 | 16.48% |
| Sep 30, 2025 | 18.69% |
| Jun 30, 2025 | -18.03% |
| Mar 31, 2025 | -24.32% |
| Dec 31, 2024 | -24.21% |
| Sep 30, 2024 | -46.38% |
| Jun 30, 2024 | -39.28% |
| Mar 31, 2024 | -36.95% |
| Dec 31, 2023 | -28.08% |
| Sep 30, 2023 | -37.04% |
| Jun 30, 2023 | -15.08% |
| Mar 31, 2023 | -37.34% |
| Dec 31, 2022 | -17.31% |
| Sep 30, 2022 | -16.21% |
| Jun 30, 2022 | -27.41% |
| Mar 31, 2022 | -25.65% |
| Dec 31, 2021 | -18.15% |
| Sep 30, 2021 | -68.42% |
| Jun 30, 2021 | -16.15% |